|
| |
 |
 |
ENS@T SC Members
For more information on an ENS@T SC Member click on one of the names below: |
ESF-ENS@T SC Members
For more information on an ESF-ENS@T SC Members click here to visit the esf website. |
| |
|
Wiebke Arlt, Birmingham, UK
|
Wiebke Arlt, Birmingham, UK |
| Jerome Bertherat, Paris, France (T) |
Xavier Bertagna, Paris, France (C) |
| Felix Beuschlein, Munich, Germany (C) |
Mihail Coculescu, Bukarest, Roumania |
| Massimo Mannelli, Florence, Italy |
Rolf Gaillard, Lausanne, Switzerland |
| Pierre-Francois Plouin, Paris, France (S) |
Bruno Niederle, Wien, Austria |
| Massimo Terzolo, Turin, Italy |
Martin Reincke, Munich, Germany |
| |
Britt Skogseid, Uppsala, Sweden |
| |
Halfdan Sorbye, Bergen, Norway |
|
|
|
| |
|
 |
| |
|
 |
Wiebke Arlt Professor of Medicine
Wiebke Arlt is Professor of Medicine and Head of the Centre for Endocrinology, Diabetes and Metabolism (CEDAM) within the School of Clinical & Experimental Medicine at the University of Birmingham. She is a Consultant Endocrinologist at the University Hospital Birmingham, the Birmingham Women’s Hospital and the Birmingham Children’s Hospital. Her clinical work focuses on adrenal, pituitary and reproductive endocrinology including adrenal tumours, adrenal insufficiency, congenital adrenal hyperplasia, Cushing’s and androgen excess disorders, e.g. polycystic ovary syndrome.
She is a committed clinician scientist and heads a large research group working on basic and clinical aspects of adrenal and gonadal disorders, with a particular focus on steroid endocrinology including steroid analysis by mass spectrometry techniques. Her research is supported mainly by the Medical Research Council UK (MRC Senior Fellowship, Programme Grant, Biomarker Grant).
Wiebke Arlt serves on the Executive Committee of the European Society of Endocrinology and on several committees of the Society for Endocrinology United Kingdom; she is also a member of the MRC Training & Research Oversight Group. She is a steering committee member of the European Network for the Study of Adrenal Tumours, ENS@T, and the FP7 European Collaborative Network on Disordered Sex Development, EuroDSD; she participate in EU Marie Curie ITNs and hosts EU Marie Curie fellows.
She is an editorial board member of the European Journal of Endocrinology, Journal of Endocrinology and Journal of Clinical Endocrinology & Metabolism.
|
| |
|
 |
| |
|
|
|
Xavier
Bertagna Professor
of Endocrinology
Xavier
Bertagna is Professor of Endocrinology, Chief of the
Department of Endocrinology of Cochin hospital, Faculté
de Médecine René Descartes, Université
Paris 5, Paris, France.
He
trained at the Clinical Research Center of Montreal
(Dr. M. Chrétien), and at the Endocrine Division,
Vanderbilt Medical School, Nashville (Dr. D. Orth).
His research interest is in endocrine tumors, adrenal
cancer, Cushing's syndrome, disorders of the pituitary-adrenal
axis, polypeptide hormone precursors, and takes place
in the Endocrinology Department of Institut Cochin (INSERM
U-567).
Xavier
Bertagna is involved in many National and International
Professional bodies; he is presently a member of the
Executive Committee of the International Society of
Endocrinology. |
| |
|
 |
| |
|
|
|
Jérôme Bertherat Professor of Endocrinology
Jérôme Bertherat is professor of Endocrinology at Paris Descartes University, head of the Center for Rare Adrenal Diseases in Cochin Hospital and the leader of the research team “endocrine tumors and signaling” in the Endocrinology, Cancer & Metabolism Department of the Cochin Institute (INSERM U567 & CNRS UMR8104), Paris, France.
His main research specialties include endocrine tumors, the genetics of familial endocrine tumors and Cushing’s syndrome.
In the focus of ENSAT his research team studies the molecular genetics of adrenocortical tumors in order to both improve diagnosis and classification, and unravel the pathogenesis of these tumors. These studies are done in the Cochin Institute with various large scale genomics approaches using mainly dna chips. Recent results and ongoing projects are dedicated to the molecular diagnosis of adrenocortical tumors using transcriptome and CGH analysis and the identification of new genes responsible for familial adrenocortical tumors. His research team is also studying genetic and signaling alterations of the cAMP and Wnt/b-catenin pathways in adrenocortical tumors and the hereditary multiple neoplasia syndrome Carney complex.
These researches are supported by INCa (National Cancer Institute), ANR (National Research Agency) and the Carte d’Identité des Tumeurs program from the Ligue contre le Cancer association.
Jérôme Bertherat is member of several International Scientific Societies and is at present deputy Chief Editor of the European Journal of Endocrinology. |
| |
|
 |
| |
|
 |
Pierre-Francois
Plouin Professor
of Medicine
Pierre-François
Plouin is Professor of Medicine and head of the Hypertension
unit, Hôpital Européen Georges Pompidou,
Assistance Publique-Hôpitaux de Paris and Faculté
de Médecine René Descartes Paris-5.
His
research specialties include renovascular and endocrine
hypertension.
Specifically,
Professor Plouin is the chairman of the French adrenal
Network COMETE, founded in 1993. |
| |
|
 |
| |
|
 |
Martin
Heinrich Reincke Professor of Medicine
Martin
Heinrich Reincke is the director of the Medizinische
Klinik - Innenstadt, Ludwig-Maximilians University in
Munich and chair of the Department of Endocrinology
and Diabetology. The Medizinische Klinik - Innenstadt
is part of Ludwig-Maximilians University, one of the
leading institutions in German academic medicine.
His
research specialities include adrenal physiology and
pathophysiology, endocrine hypertension, pituitary disease,
mineralocorticoid and glucocorticoid action and stress
research. Professor Reincke is heading a research team
specifically exploring the prevalence and relevance
of mineralocorticoid excess in resistant hypertension
on the epidemiological, clinical, genetic and molecular
level. The research teams of his clinic have particular
expertise in assay development and validation for endocrine
disease, development of genetically manipulated animals
as models for human adrenal disease.
Professor
Reincke was previously head of the Section of Endocrinology
at the University Hospital of Freiburg (1989 to 2004)
before moving to Munich. He is a member of many national
and international societies. He has served in the Executive
Board of the German Endocrine Society, is on the editorial
board of several international journals, and currently
serves as faculty dean of the university.
|
| |
|
 |
| |
|
 |
Felix Beuschlein Professor
of Medicine
Felix Beuschlein is the Head of Endocrine Research at the Medizinische Klinik - Innenstadt, Ludwig-Maximilians University in Munich. The Medizinische Klinik - Innenstadt is part of Ludwig-Maximilians University, one of the leading institutions in German academic medicine.
His research specialties include adrenal physiology and pathophysiology, endocrine hypertension, and stress research. Professor Beuschlein is heading a research team specifically unraveling mechanisms involved in the regulation of growth and differentiation of the adrenal cortex during development, during adaptation in the adult organism and in the context of adrenal tumorigenesis. Complementary to this in vitro and in vivo model based research molecular characterization and expression profiling in a variety of patients’ tumor samples are performed and correlated with clinical data and outcome measures. In close cooperation with national and international partners Prof. Beuschlein’ team is aiming to gain insides in disease relevant mechanisms that translate into improvement of care after testing in clinical studies.
Professor Beuschlein is a member of many national and international societies. Currently he is serving as the head of the Section Adrenal, Steroids and Hypertension of the German Endocrine Society. |
| |
|
 |
| |
|
 |
Massimo Mannelli
Professor of Endocrinology
Prof.
Mannelli is Full Professor of Endocrinology in the Department
of Clinical Pathophysiology , University of Florence.
He is Senior Lecturer in Endocrinology at the Postgraduate
School of Endocrinology, University of Florence.
He
is member of the Italian Society of Endocrinology, the
Italian Society of Hypertension and the Endocrine Society.
In the period 2002-2005 he was the coordinator of the
Scientific Committee of the Italian Society of Hypertension.
Prof.
Mannelli has a wide experience in clinical endocrinology
in view of his responsibility in the In patient Clinic
and Day Hospital Service of the Endocrinology Unit of
the University of Florence. His main research field
encompasses the pathophysiology of the sympathetic-adrenal
system as well as of the adrenal cortex and the endocrine
hypertension.
Because
of his expertise on pheochromocytoma he was invited
speaker in several international Congresses as the 8th
International Symposium on Catecholamines (Asilomar,
CA, 13-18 Oct 1996), the 19th Scientific Meeting of
the International Society of Hypertension (Prague, 23-27
June 2002), the 1st International Symposium on Pheochromocytoma
(Bethesda, October 2005).
He
published original papers on the modulation exerted
in man on catecholamine release by prostaglandins, opioids
and dopamine, on the adrenocortical cancer and on the
clinics, the biology and the genetics of pheochromocytoma. |
| |
|
 |
| |
|
 |
Massimo Terzolo Professor of Medicine
Massimo Terzolo is Associate Professor of Internal Medicine and director of the Division of Internal Medicine I, San Luigi Hospital, University of Turin, Italy.
His research specialities include adrenocortical tumors, Cushing’s syndrome and acromegaly.
Professor Terzolo is leading a research team studying novel therapeutic approaches for patients with adrenocortical cancer. Another area of specific interest is subclinical Cushing’s syndrome in patients with adrenal incidentaloma.
He is a member of several national and international societies and he has been the coordinator of many Italian multicentric studies on adrenal tumors. He is a member of the steering committees of the European Network for the Study of Adrenal Tumors, ENS@T, and of the “First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)”.
He is also the chair of the “ADIUVO” study, a multicentric, randomized trial aiming to assess the efficacy of adjuvant mitotane treatment in patients with adrenocortical cancer. |
| |
|
| |
|
 |
| |
|
|
|